DE2711686B2 - Process for the preparation of isobutyramides - Google Patents

Process for the preparation of isobutyramides

Info

Publication number
DE2711686B2
DE2711686B2 DE2711686A DE2711686A DE2711686B2 DE 2711686 B2 DE2711686 B2 DE 2711686B2 DE 2711686 A DE2711686 A DE 2711686A DE 2711686 A DE2711686 A DE 2711686A DE 2711686 B2 DE2711686 B2 DE 2711686B2
Authority
DE
Germany
Prior art keywords
general formula
bromo
cyanoalkyl
isobutyramides
conh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2711686A
Other languages
German (de)
Other versions
DE2711686A1 (en
DE2711686C3 (en
Inventor
Andre Paris Esanu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D'etudes De Produits Chimiques Sa Paris Ste
Original Assignee
D'etudes De Produits Chimiques Sa Paris Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D'etudes De Produits Chimiques Sa Paris Ste filed Critical D'etudes De Produits Chimiques Sa Paris Ste
Publication of DE2711686A1 publication Critical patent/DE2711686A1/en
Publication of DE2711686B2 publication Critical patent/DE2711686B2/en
Application granted granted Critical
Publication of DE2711686C3 publication Critical patent/DE2711686C3/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

Bevorzugt beginnt die Synthese mit p-Fluor- oder p-Bromphenol, das in das Natriumphenolat (I) durch Umsetzung mit Natrium in Äthanollösung überführt wird. Das Äthanol wird dann durch Zugabe eines Überschusses an Toluol und anschließende Destillation des Azeotrops durch Toluol ersetzt.The synthesis preferably begins with p-fluoro or p-bromophenol, which is converted into the sodium phenolate (I) Reaction with sodium in ethanol solution is transferred. The ethanol is then added by adding a Excess of toluene and subsequent distillation of the azeotrope replaced by toluene.

Zu der Lösung in Toluol gibt man das N-Cyanoalkyl-a-brom-isobutyramid der Formel (II), und dann wird das Reaktionsgemisch bevorzugt während 6 bis 15 Stunden am Rückfluß erhitzt.The N-cyanoalkyl-a-bromo-isobutyramide is added to the solution in toluene of formula (II), and then the reaction mixture is preferably during 6 to Heated under reflux for 15 hours.

Die nach dem erfindungsgemäßen Verfahren hergestellten Verbindungen sind pharmakologisch wirksam und zeigen hypolipämische, hypotriglyceridämische und hypocholesterinämische Aktivität.The compounds prepared by the process according to the invention are pharmacologically active and show hypolipemic, hypotriglyceridemic, and hypocholesterolemic activity.

Die folgenden Beispiele erläutern die Erfindung.The following examples illustrate the invention.

Beispiel 1
N-Cyanoäthyl-p-chlorphenoxy-isobutyramid
example 1
N-cyanoethyl-p-chlorophenoxy-isobutyramide

In einen 25-I-Reaktor, der mit Kühl- und Riihreinrichtungen ausgerüstet ist, gibt man 3 I Äthanol, 60 g Natnum und 250 g p-Chlorphenol (1,944 Mol). Nach einstündigem Rühren gibt man 2 1 Toluol hinzu und das Äthanol/Toluol-Azeotrop wird durch Destillation entfernt. Weitere 21 Toluol werden zugegeben. Dann werden 425 g N-Cyanoäthyl-\-bromisobutyramid (1,944 Mol) zugesetzt.3 l of ethanol, 60 g of sodium and 250 g of p-chlorophenol (1.944 mol) are placed in a 25 l reactor equipped with cooling and stirring devices. After stirring for one hour, 2 l of toluene are added and the ethanol / toluene azeotrope is removed by distillation. Another 21 toluene are added. Then 425 g of N-cyanoethyl - \ - bromoisobutyramide (1.944 mol) are added.

Das Reaktionsgemisch wird K) h am Rückfluß erhitzt. Dann werden 2 I Toluol abdestilliert. Das entstehende Gemisch wird mit Wasser behandelt; man erhält einen Niederschlag. Dieser wird abfiltrierl, mit Wasser gewaschen und bis zur neutralen Reaktion mit HCl angesäuert. Er wird getrocknet und aus Diisopropyläther kristallisiert.The reaction mixture is refluxed for K) h. Then 2 l of toluene are distilled off. That resulting mixture is treated with water; a precipitate is obtained. This is filtered off, washed with water and acidified with HCl until neutral. He is dried and off Diisopropyl ether crystallizes.

Man erhält so 348 g (Ausbeute 67%) eines weißen, kristallinen Produktes, F. 710C. Die Zusammensetzung des Produktes entspricht der Formel C13H15CIOaN2 (Molekulargewicht 266,72). Die Verbindung ist in Wasser unlöslich, aber löslich in den meisten üblichen organischen Lösungsmitteln.Are thus obtained 348 g (yield 67%) of a white crystalline product, mp 71 0 C. The composition of the product corresponds to the formula C 13 H 15 CIOaN 2 (molecular weight 266.72). The compound is insoluble in water, but soluble in most common organic solvents.

ίο B e i s ρ i e 1 2ίο B e i s ρ i e 1 2

N-Cyanoäthyl-p-fiuorphenoxy-isobutyramidN-cyanoethyl-p-fluorophenoxy-isobutyramide

Das Verfahren von Beispiel I wird wiederholt, mit der Ausnahme, daß das p-Chlorphenol durch is ρ-Fluorphenol ersetzt wird, das nach der Behandlung mit Natrium mit N-Cyanoäthyl-A-bromisobutyramid umgesetzt wird.The procedure of Example I is repeated except that the p -chlorophenol is through is ρ-fluorophenol that is replaced after treatment with sodium with N-cyanoethyl-A-bromoisobutyramide is implemented.

Man erhält ein weißes, kristallines Produkt, F. 75'C, in einer Ausbeute von 67%. Die Analyse zeigt gute Ubereinsiimmung mit der Formel CnH15FNiO-. (Molekulargewicht 250,2).A white, crystalline product, melting point 75 ° C., is obtained in a yield of 67%. The analysis shows good agreement with the formula CnH 15 FNiO-. (Molecular weight 250.2).

Beispiel 3
N-Cyanobutyl-p-chlorphenoxy-isobutyramid
Example 3
N-cyanobutyl-p-chlorophenoxy-isobutyramide

Das Verfahren von Beispiel I wird wiederholt, mil der Ausnahme, daß N-Cyanoäthyl-.\-brom-isobutyramiJ durch N-Cyanobutyl-.n-brom-isobutyramid ersetzt wird. Die Ausbeute beträgt 87% an einem in weißen, kristallinen Produkt, F. 88' C. Die Analyse zeigt gute Übereinstimmung mit der Formel C15H19CIN2O2.The procedure of Example I is repeated with the exception that N-cyanoethyl-. \ - bromo-isobutyramide is replaced with N-cyanobutyl-.n-bromo-isobutyramide. The yield is 87% of a white, crystalline product, mp 88 ° C. The analysis shows good agreement with the formula C 15 H 19 CIN 2 O 2 .

Claims (1)

1 21 2 Patentanspruch:
Verfahren zur Herstellung von Isobutyramiden der allgemeinen Formel
Claim:
Process for the preparation of isobutyramides of the general formula
CH,CH, R'—Z^V-O—C—CO—NH—(CH2Jn-CN CH,R'— Z ^ VO — C — CO — NH— (CH 2 J n -CN CH, in der R1 ein Fluor- oder Chloratom und η eine ganze Zahl von 2 bis 4 bedeuten, dadurch gekennzeichnet, daß man ein Natriumphenolat der allgemeinen Formel 1in which R 1 is a fluorine or chlorine atom and η is an integer from 2 to 4, characterized in that a sodium phenolate of the general formula 1 -ONa (1)-ONa (1) in an sich bekannter Weise mit einem N-Cyanoalkyl-A-brom-isobulyramid der allgemeinen Formel Ilin a manner known per se with an N-cyanoalkyl-A-bromo-isobulyramide of the general formula II CH,
Br-C-CONH-(CH-On-CN (II)
CH,
Br-C-CONH- (CH-O n -CN (II)
CH,
wobei R1 und η die oben gegebenen Bedeutungen besitzen, in einem nichtpolaren Lösungsmittel umsetzt.
CH,
where R 1 and η have the meanings given above, in a non-polar solvent.
Die Erfindung betrifft ein Verfahren zur Herslellung von Isobutyramiden der allgemeinen FonrHThe invention relates to a process for the preparation of isobutyramides of the general FonrH CH,CH, R'--/~~\—O—C—CO —NH-(CH2),-CN CH,R '- / ~~ \ —O — C — CO —NH- (CH 2 ), - CN CH, in der R1 ein Fluor- oder Chloratom und n eine ganze maß durch Einwirkung des entsprechend substituier-Zahl von 2 bis 4 bedeuten. ten Natriumphenolats der allgemeinen Formel Iin which R 1 is a fluorine or chlorine atom and n is an integer from 2 to 4 by the action of the corresponding substitution number. ten sodium phenolate of the general formula I. Die obigen Verbindungen werden erfindungsge-The above compounds are inventively R1 \ /-QNa (l) R1 \ / - QNa (l) in einem nichtpolarcn Lösungsmittel auf ein N-Cyanoalkyl-A-brom-isobulyramid der allgemeinen Formel Ilin a non-polar solvent to an N-cyanoalkyl-A-bromo-isobulyramide of the general formula II CH,CH, Br—C-CONH-(CH2),,-CN (II)Br — C-CONH- (CH 2 ) ,, - CN (II) CH.,CH., wobei R' und /? die oben gegebenen Bedeutungen leicht durch Umsetzung von n-Brom-isobutyrylehloridwhere R 'and /? the meanings given above easily by reacting n-bromo-isobutyrylehlorid besitzen, in an sich bekannter Weise hergestellt. t>o und dem geeigneten omega-Aminonitril entsprechendown, produced in a known manner. t> o and the appropriate omega-aminonitrile accordingly Das N-Cyanoalkyl-s-brom-isobutyramid (II) kann dem folgenden Reaktionsschema erhalten werden:The N-cyanoalkyl-s-bromo-isobutyramide (II) can be obtained from the following reaction scheme: CH3 CH,CH 3 CH, I ' II 'I Br-C—COCI + H2N-(CHOn-CN — Br-C-CONH(CH2JnCNBr-C-COCI + H 2 N- (CHO n -CN - Br-C-CONH (CH 2 J n CN I " II "I CH, CH,CH, CH,
DE2711686A 1976-03-17 1977-03-17 Process for the preparation of isobutyramides Expired DE2711686C3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB10634/76A GB1518764A (en) 1976-03-17 1976-03-17 Isobutyramides their preparation and therapeutic composititions containing them

Publications (3)

Publication Number Publication Date
DE2711686A1 DE2711686A1 (en) 1977-09-29
DE2711686B2 true DE2711686B2 (en) 1979-04-12
DE2711686C3 DE2711686C3 (en) 1979-11-29

Family

ID=9971495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2711686A Expired DE2711686C3 (en) 1976-03-17 1977-03-17 Process for the preparation of isobutyramides

Country Status (18)

Country Link
US (1) US4131617A (en)
JP (1) JPS52113932A (en)
AR (1) AR213430A1 (en)
AT (1) AT346315B (en)
BE (1) BE852557A (en)
CH (1) CH598201A5 (en)
DE (1) DE2711686C3 (en)
DK (1) DK118177A (en)
ES (1) ES456943A1 (en)
FR (1) FR2344528A1 (en)
GB (1) GB1518764A (en)
MX (1) MX4593E (en)
MY (1) MY8000099A (en)
NL (1) NL7702892A (en)
NZ (1) NZ183560A (en)
OA (1) OA05605A (en)
PT (1) PT66305B (en)
ZA (1) ZA771613B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965825A (en) 1981-11-03 1990-10-23 The Personalized Mass Media Corporation Signal processing apparatus and methods
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
WO1995011699A1 (en) * 1993-10-29 1995-05-04 The Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
CA2324426A1 (en) * 1998-02-11 1999-08-19 Douglas V. Faller Compositions and methods for the treatment of cystic fibrosis
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
WO2011038224A1 (en) 2009-09-24 2011-03-31 Trustees Of Boston University Methods for treating viral disorders
WO2011072086A1 (en) 2009-12-08 2011-06-16 Hemaquest Pharmaceuticals, Inc. Methods and low dose regimens for treating red blood cell disorders
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
AU2020283590A1 (en) 2019-05-31 2022-01-20 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1041982A (en) * 1963-09-30 1966-09-07 Boots Pure Drug Co Ltd Herbicidal compounds and compositions

Also Published As

Publication number Publication date
CH598201A5 (en) 1978-04-28
ATA183077A (en) 1978-03-15
AR213430A1 (en) 1979-01-31
US4131617A (en) 1978-12-26
OA05605A (en) 1981-04-30
DE2711686A1 (en) 1977-09-29
MX4593E (en) 1982-06-25
BE852557A (en) 1977-07-18
PT66305B (en) 1978-08-11
FR2344528A1 (en) 1977-10-14
PT66305A (en) 1977-04-01
DE2711686C3 (en) 1979-11-29
NL7702892A (en) 1977-09-20
AT346315B (en) 1978-11-10
JPS52113932A (en) 1977-09-24
ZA771613B (en) 1978-02-22
NZ183560A (en) 1978-07-28
JPS5647179B2 (en) 1981-11-07
DK118177A (en) 1977-09-18
FR2344528B1 (en) 1980-03-14
MY8000099A (en) 1980-12-31
GB1518764A (en) 1978-07-26
ES456943A1 (en) 1978-01-16

Similar Documents

Publication Publication Date Title
DE2711686C3 (en) Process for the preparation of isobutyramides
DE3141586A1 (en) 1,8-DIHYDROXY-9-ANTHRONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN PHARMACEUTICAL AND COSMETICS
DE2600668C2 (en) N- (1-Adamantylmethyl) -N'-cinnamylpiperazine, process for its preparation and pharmaceuticals containing it
CH621127A5 (en)
DE2065312C3 (en) Aminoethanesulfonyl derivatives and processes for their preparation
DE2462559B2 (en) 4-oximino-1-oxa-3-thiacyclopentanes and their 3-oxides or 33-dioxides and 3-oximino-1-oxa-4-thiacyclohexanes and their 4-oxides or 4,4-dioxides
DE2521347C3 (en) Hydroxyl-substituted 2-chloro-a, - (tert-butylaminomethyl) -benzyl alcohols, manufacturing processes and pharmaceuticals
DE2557033C2 (en) Acyl derivatives of 1,2-5,6-dianhydro-dulcite, processes for their preparation and anticarcinogenic agents containing these compounds
DE2737299C2 (en) Process for obtaining pure 3-phenoxybenzaldehyde
DE2542096C2 (en) Symmetrical dihydroxydithiahexadecanes, processes for their preparation and medicinal products containing them
EP0381661A1 (en) 1-E3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl]-3-phenyl-1-propanon and process for its preparation
DE1914496C3 (en) Process for the preparation of 1,2,5 thiadiazole derivatives
CH533619A (en) Phenyl-substd pyrrole derivs with anti- - inflammatory activity
DE2711738C3 (en)
DE2155857A1 (en) New chemical compounds and methods of making them
DE2201804C3 (en) Phenylethylbenzylamines and process for their preparation
DE2660902C2 (en) Dicarboxylic acid bis [3,5-bis (chlorocarbonyl) -2,4,6-triiodanilide] compounds and their preparation
DE2518516C3 (en) 2- (3,45-trimethoxybenzyl) -3,4-dimethylpyridine
DE2421999C3 (en) Vincamic acid derivatives
DE1670186C (en) p Alkoxy piperidin amide and process for their preparation
DE2360317C3 (en) Intermediate products for new phenylethylamine derivatives and processes for their preparation
AT257580B (en) Process for the preparation of new aryloxy-3-hydroxy- or -oxoalkanoic acids, their esters and salts
DE2263093A1 (en) 7-METHOXY-2,3-DIHYDROBENZOFURA DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION
DE2338972A1 (en) MAGNESIUM GRIGNARD COMPOUNDS AND THEIR USE
DE2350395C3 (en) N- (m-Trifluoromethylthiophenyl) piperazine, its salts, process for their preparation and their use as an intermediate compound for the preparation of piperazine derivatives

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee